You have 9 free searches left this month | for more free features.

Sarcoidosis

Showing 26 - 50 of 695

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sarcoidosis Trial in Durham

Recruiting
  • Sarcoidosis
    • Durham, North Carolina
      Duke University Medical Center
    Jun 29, 2022

    Mediastinal Lymphadenopathy, Sarcoidosis, Pulmonary, Mediastinal Diseases Trial in Washington (Endobronchial Ultrasound-Guided

    Not yet recruiting
    • Mediastinal Lymphadenopathy
    • +2 more
    • Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy
    • Washington, District of Columbia
      The George Washington University Hospital
    Oct 11, 2022

    Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)

    Not yet recruiting
    • Obesity
    • +4 more
    • Semaglutide Pen Injector
    • (no location specified)
    Feb 15, 2023

    Sarcoidosis With Myocarditis, Sarcoidosis, Healthy Trial in Iowa City (cell free DNA)

    Recruiting
    • Sarcoidosis With Myocarditis
    • +3 more
    • cell free DNA
    • Iowa City, Iowa
    • +1 more
    May 16, 2022

    Sarcoidosis, Pulmonary Trial in United States (Namilumab, Placebo)

    Recruiting
    • Sarcoidosis, Pulmonary
    • Gainesville, Florida
    • +3 more
    Aug 3, 2022

    Role of Genetic Factors in the Development of Lung Disease

    Recruiting
    • Cystic Fibrosis
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Sarcoidosis, Cardiac Trial in Gainesville, Baltimore (Namilumab, Placebo, Open label Namilumab)

      Recruiting
      • Sarcoidosis, Cardiac
      • Gainesville, Florida
      • +1 more
      Aug 5, 2022

      Sarcoidosis, Pulmonary Trial in Chandigarh (Narrow band imaging bronchoscopy guided endobronchial biopsy, White light

      Recruiting
      • Sarcoidosis, Pulmonary
      • Narrow band imaging bronchoscopy guided endobronchial biopsy
      • White light bronchscopy guided endobronchial biopsy
      • Chandigarh, India
        Postgraduate Institute of Medical Education and Research
      Apr 5, 2022

      Pulmonary Sarcoidosis Trial (Hydroxychloroquine + low-dose prednisone, Prednisone)

      Not yet recruiting
      • Pulmonary Sarcoidosis
      • (no location specified)
      Feb 9, 2022

      Sarcoid, Cardiovascular Diseases, Cancer Trial in Boston ([64]Cu Macrin)

      Recruiting
      • Sarcoid
      • +2 more
      • [64]Cu Macrin
      • Boston, Massachusetts
      • +1 more
      Jun 22, 2022

      Fibrosing ILD Biomarkers That Rule Acceleration

      Recruiting
      • Pulmonary Fibrosis
      • Sarcoidosis
      • Comprehensive clinical assessment and biological samples collection
      • Porto, Portugal
        Centro Hospitalar Universitário São João
      Jan 12, 2023

      Sarcoidosis, Cutaneous Sarcoidosis Trial in Stanford (Humira)

      Withdrawn
      • Sarcoidosis
      • Cutaneous Sarcoidosis
      • Stanford, California
        Stanford University
      Feb 3, 2022

      Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)

      Completed
      • Sarcoidosis, Pulmonary
      • +2 more
      • Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
      • +5 more
      • Portland, Oregon
        Oregon Health & Science University
      Dec 3, 2021

      Urinary Metabolome in Sarcoidosis

      Completed
      • Sarcoidosis
        • Bobigny, France
          Hopital Avicenne,AP-HP
        Dec 20, 2021

        Obstructive Sleep Apnoea in Sarcoidosis

        Completed
        • Sarcoidosis
        • +3 more
        • Home sleep apnea testing
        • Zürich, Switzerland
          University Hospital Zurich
        Jan 13, 2022

        Cardiac Sarcoidosis Trial in Vancouver (18F-Fluorodeoxyglucose (18F-FDG) PET/CT)

        Approved for marketing
        • Cardiac Sarcoidosis
        • 18F-Fluorodeoxyglucose (18F-FDG) PET/CT
        • Vancouver, British Columbia, Canada
          BC Cancer Agency
        Feb 2, 2022

        Pulmonary Sarcoidosis Trial in Cleveland (Efzofitimod 3 mg/kg, Efzofitimod 5 mg/kg, Placebo)

        Recruiting
        • Pulmonary Sarcoidosis
        • Efzofitimod 3 mg/kg
        • +2 more
        • Birmingham, Alabama
        • +22 more
        Dec 1, 2022

        Sarcoidosis Trial in Palo Alto (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1, Placebos)

        Active, not recruiting
        • Sarcoidosis
        • Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1
        • Placebos
        • Palo Alto, California
          Stanford University
        Jan 12, 2022

        Health-related Quality of Life Tool for Cardiac Sarcoidosis

        Recruiting
        • Cardiac Sarcoidosis
          • Cambridge, United Kingdom
          • +1 more
          Jan 26, 2022

          Pulmonary Sarcoidosis Trial in Columbus (nicotine patch)

          Completed
          • Pulmonary Sarcoidosis
          • nicotine patch
          • Columbus, Ohio
            The Ohio State University
          Nov 1, 2021

          Pulmonary Sarcoidosis Trial in Worldwide (CMK389, Placebo)

          Recruiting
          • Pulmonary Sarcoidosis
          • Birmingham, Alabama
          • +27 more
          Nov 2, 2022

          Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

          Recruiting
          • Squamous Cell Carcinoma of Head and Neck
          • +7 more
          • Brussels, Brussel, Belgium
            Uz Brussel
          Sep 2, 2022

          Sarcoidosis Trial in Columbus (Habitrol, Placebo to Habitrol)

          Completed
          • Sarcoidosis
          • Columbus, Ohio
            Martha Morehouse Medical Pavilion 2050 Kenny Rd; Ste 2600
          Nov 1, 2021

          Myocarditis, Cardiac Sarcoidosis, Pericarditis Trial in Bern

          Enrolling by invitation
          • Myocarditis
          • +2 more
            • Bern, Switzerland
              Department of Cardiology, University Hospital Bern, Inselspital,
            May 17, 2022

            Development of a Novel Human In Vitro Sarcoidosis Model

            Completed
            • Sarcoidosis
            • No intervention, observational study only
            • Columbus, Ohio
              Biomedical Research Tower, 10th floor
            Nov 1, 2021